Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Venture capital fund investing in biopharmaceuticals and medical technologyFund terms
Fund manager
Fund type
Funding
Funding rounds
Fund Closing USD 697,000,000
USD 697,000,000
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
ATP Private Equity Partners III K/S | Denmark |
Cap Table
Current and past shareholders
| Investor | Round | |
|---|---|---|
|
|
ATP Private Equity Partners III K/S |
Fund Closing |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
TetraLogic Pharmaceuticals A leader in the discovery and development of small molecule drugs called Smac mimetics for the treatment of cancers. |
United States | 1 Aug 2010 | Series C |
|
|
Neomend Inc A biomedical device company, engages in the development and commercialization of surgical wound healing products |
United States | 1 Jan 2010 | Series D Active |
|
|
|
SFJ Phamaceuticals Inc A specialty pharmaceutical company, engages in the clinical development and registration of pharmaceutical products in Japan. |
United States | N/A |
||
|
Restoration Robotics Inc |
United States | N/A Active |
||
|
|
Ophthotech Corp Clinical-stage biotechnology company, engages in developing and commercializing therapies for wet and dry age-related macular degeneration. |
United States | N/A |